HOUSTON (AP) — HOUSTON (AP) — Alaunos Therapeutics, Inc. (TCRT) on Monday reported a loss of $8.8 million in its second quarter.

On a per-share basis, the Houston-based company said it had a loss of 4 cents.

The drug developer posted revenue of $4,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TCRT at https://www.zacks.com/ap/TCRT

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News